REGIS HEALTHCARE LIMITED (REG)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

REG - REGIS HEALTHCARE LIMITED

FNArena Sector : Aged Care & Seniors
Year End: June
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: 0.05
Index: ASX300 | ALL-ORDS

LAST PRICE CHANGE +/- CHANGE % VOLUME

$6.44

20 Nov
2024

0.100

OPEN

$6.28

1.58%

HIGH

$6.51

513,607

LOW

$6.24

TARGET
$6.45 0.2% upside
Franking for last dividend paid out: 50%
OTHER COMPANIES IN THE SAME SECTOR
EGH . INA . LIC . OCA .
FNARENA'S MARKET CONSENSUS FORECASTS
REG: 1
Title FY23
Actual		 FY24
Actual		 FY25
Forecast		 FY26
Forecast
EPS (cps) xxx - 7.1 18.8 xxx
DPS (cps) xxx 12.9 14.9 xxx
EPS Growth xxx N/A N/A xxx
DPS Growth xxx 36.3% 14.9% xxx
PE Ratio xxx N/A 34.3 xxx
Dividend Yield xxx N/A 2.3% xxx
Div Pay Ratio(%) xxx N/A 79.2% xxx

Dividend yield today if purchased 3 years ago: 6.80%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 2.01

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 10/09 - ex-div 6.65c (franking 50%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic xxxxxxxxxxxxxxx-7.1
DPS All xxxxxxxxxxxxxxx12.9
Sales/Revenue xxxxxxxxxxxxxxx1,005.8 M
Book Value Per Share xxxxxxxxxxxxxxx-7.6
Net Operating Cash Flow xxxxxxxxxxxxxxx252.3 M
Net Profit Margin xxxxxxxxxxxxxxx-2.13 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed xxxxxxxxxxxxxxx-276.16 %
Return on Invested Capital xxxxxxxxxxxxxxx-48.28 %
Return on Assets xxxxxxxxxxxxxxx-1.22 %
Return on Equity xxxxxxxxxxxxxxx-276.16 %
Return on Total Capital xxxxxxxxxxxxxxx-98.47 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx145.2 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt xxxxxxxxxxxxxxx1 M
Long Term Debt xxxxxxxxxxxxxxx3 M
Total Debt xxxxxxxxxxxxxxx4 M
Goodwill - Gross xxxxxxxxxxxxxxx386 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx65 M
Price To Book Value xxxxxxxxxxxxxxx-

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex xxxxxxxxxxxxxxx65.7 M
Capex % of Sales xxxxxxxxxxxxxxx6.53 %
Cost of Goods Sold xxxxxxxxxxxxxxx967 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx83 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx118 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

2
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Macquarie

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

16/09/2024

1

Buy

$6.40

-0.62%

In response to the Federal Governments Aged Care Taskforce changes, Ord Minnett upgrades the earnings outlook for Regis Healthcare.

The broker forecasts incremental EBITDA of $48m to the company by FY28 or $17 per resident, per day.

EPS forecasts are lifted by 14% in FY25 and 31% in FY26.

Buy rating unchanged. Target price rises to $6.40 from $4.90.

FORECAST
Ord Minnett forecasts a full year FY25 dividend of 15.70 cents and EPS of 23.10 cents.
Ord Minnett forecasts a full year FY26 dividend of 21.70 cents and EPS of 38.10 cents.
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Jarden

16/09/2024

2

Overweight

$4.46

-30.75%

Jarden notes the Federal Government's Aged Care reform will take two and a half years to have a full financial impact on companies like Regis Healthcare.

The analyst estimates $27.5m in additional income per annum for the company which will be forthcoming in FY28/FY29 or an 18% rise to EBITDA over this period compared to current forecasts.

There are no changes to the broker's earnings forecasts.

Overweight rating and $4.46 target price remain.

FORECAST
Jarden forecasts a full year FY25 dividend of 4.00 cents and EPS of 19.60 cents.
Jarden forecasts a full year FY26 dividend of 6.00 cents and EPS of 22.40 cents.
Access Extra Coverage Research History >

REG STOCK CHART

FNArena News on REG

1
Rudi’s View: The Importance Of ‘Quality’ Growth

3:18 PM - Rudi's View
2
Rudi’s View: A Rally With No Earnings Support

Nov 14 2024 - Rudi's View
3
Rudi’s View: Trump Returns, What Now?

Nov 07 2024 - Rudi's View
4
Rudi’s View: US Earnings & The Election

Oct 31 2024 - Rudi's View
5
Rudi’s View: Earnings, Best Ideas & Favourite Stock Picks

Oct 24 2024 - Rudi's View

Latest Aged Care & Seniors News

1
Treasure Chest: Regis Healthcare

Sep 18 2024 - Treasure Chest
2
Treasure Chest: Lifestyle Communities En Vogue

Mar 19 2024 - Treasure Chest
3
Lifestyle Communities Enjoying Strong Demand

Feb 21 2022 - Small Caps
4
Aged Care Sector: Poised

Mar 16 2021 - Australia
5
Pressure Grows On Estia Health

Dec 10 2019 - Australia
6
Aveo Group Now A Binary Proposition

Jun 26 2019 - Australia
7
Aged Care Moves Into The RC Spotlight

Sep 20 2018 - Australia
8
Regis Healthcare In Strong Shape For FY19

Sep 04 2018 - Australia
9
Gateway Pays Up For Expansion

Mar 20 2018 - Small Caps
10
Challenging FY18 For Japara Healthcare

Dec 20 2017 - Small Caps